A number of investment brokers have recently updated their price targets on shares of Aerie Pharmaceuticals, Inc. (AERI). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/18/2016 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 40 price target on the stock.

02/18/2016 – Aerie Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 50 price target on the stock.

11/05/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 44 price target on the stock.

10/02/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Brean Capital. They now have a USD 48 price target on the stock.

09/17/2015 – Aerie Pharmaceuticals, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 49 price target on the stock.

09/17/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 45 price target on the stock.

06/03/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Piper Jaffray. They now have a USD 9 price target on the stock.

05/01/2015 – Aerie Pharmaceuticals, Inc. was upgraded to “hold” by analysts at Zacks.

04/24/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 30 price target on the stock.

03/24/2015 – Aerie Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 40 price target on the stock.

The share price of Aerie Pharmaceuticals, Inc. (AERI) was down -7.44% during the last day of trading, with a day high of 14.66. 520478 shares were traded during the last session.

The stock’s 50 day moving average is 14.38 and its 200 day moving average is 18.82. The stock’s market capitalization is 354.33M. Aerie Pharmaceuticals, Inc. has a 52-week low of 10.50 and a 52-week high of 33.25.

View other investors thoughts on Aerie Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.